跳至主要内容
临床试验/NL-OMON40138
NL-OMON40138已完成不适用

IMproved Pregnancy Outcomes by Early Detection; personalised medicine for pregnant women: novel metabolomic and proteomic biomarkers to detect pre-eclampsia and improve outcome. - IMPROvED

niversity College Cork, Ireland0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
12 至 99(—)

入选标准

  • nulliparous women
  • 16 year or older
  • singleton pregnancy
  • between 9+0 and 16+6 weeks gestation

排除标准

  • unsure term of pregnancy, 3 or more miscarriages or terminations, known or suspected fetal anomaly, essential hypertension or hypertension at booking, diabetes, renal disease, Systemic Lupus Erythematosus, Anti-phospholipid Syndrome, Sickle Cell Disease, HIV positive, Hepatitis B or C positive, major uterine anomaly, cervical suture in situ, knife cone biopsy, long term steroids, treatment low-dow aspirin/LMVW heparin

研究者

发起方
niversity College Cork, Ireland

相似试验

IMproved Pregnancy Outcomes by Early Detection;... | 临床试验